5 things to watch on the ASX 200 on Monday

Beach Energy Ltd (ASX:BPT), Qantas Airways Limited (ASX:QAN), and ResMed Inc. (ASX:RMD shares will be on watch on the ASX 200 on Monday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Friday the S&P/ASX 200 index ended the week with a small gain. The benchmark index rose 0.1% to finish it at 7,017.2 points.

Will the local share market be able to build on this on Monday? Here are five things to watch:

a woman

ASX 200 expected to sink lower.   

The S&P/ASX 200 index looks set to start the week on a very disappointing note. According to the latest SPI futures, the ASX 200 is poised to crash 119 points or 1.7% lower at the open. This follows a bad end to the week on Wall Street which saw the Dow Jones drop 2.1%, the S&P 500 index fall 1.8%, and the Nasdaq index tumble 1.6%.

Coronavirus concerns escalate.

Global markets were sold off on Friday after coronavirus concerns continued to escalate. With more and more cases being reported, Qantas Airways Limited (ASX: QAN) has followed the lead of many of its peers by announcing plans to stop all flights to and from the China mainland.

Oil prices drops lower.

Energy producers including Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could drop lower on Monday after oil prices weakened again. According to Bloomberg, the WTI crude oil price fell 1.1% to US$51.56 a barrel and the Brent crude oil price dropped 1.2% to US$56.62 a barrel.

Gold price softens.

Gold miners such as Newcrest Mining Limited (ASX: NCM) and St Barbara Ltd (ASX: SBM) will be on watch after the gold price softened despite the global market turmoil. According to CNBC, the spot gold price fell 0.1% to US$1,587.90 an ounce on Friday night.

ResMed rated as a buy.

The ResMed Inc. (ASX: RMD) share price could still go higher from here according to analysts at Goldman Sachs. According to a note out of the investment bank, its analysts have retained their buy rating and lifted the price target on its shares to $27.50. Goldman was impressed with its first half performance and appears confident its strong form can continue.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »